Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders, Softcover reprint of the original 1st ed. 2016

Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed.

Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice. 

1. Pharmacogenetics of the Efficacy of Antipsychotic Drugs in Schizophrenia.- 2. Pharmacogenetics of Serious Antipsychotic Side-Effects.- 3. Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs.- 4. Genomic Studies of Treatment Resistance in Major Depressive Disorders.- 5. Complementation of Pharmacogenetics with Biomarkers and Neuroimaging in Major Depression.- 6. Pharmacogenetics of Mood Stabilizers.- 7. Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant and Mood-Stabilizing Drugs.

Updated comprehensive review of the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression

Modern pharmacogenomics of the most important psychotropic drugs such as antipsychotics, antidepressants and mood stabilizers

The attempts to use pharmacogenetics of antipsychotics, antidepressant and mood-stabilizing drugs in practice

Perspectives for future research in pharmacogenetics in major psychoses